| 1 |
25815518 | Synergistic effects of valproic acid and arsenic trioxide on RPMI8226 cells in vitro and the possible underlying mechanisms. | 2015 Jul |
1 |
| 2 |
26692822 | Arsenic trioxide reduces chemo-resistance to 5-fluorouracil and cisplatin in HBx-HepG2 cells via complex mechanisms. | 2015 |
1 |
| 3 |
24627159 | Arsenic hexoxide enhances TNF-α-induced anticancer effects by inhibiting NF-κB activity at a safe dose in MCF-7 human breast cancer cells. | 2014 May |
1 |
| 4 |
25130820 | [Apoptosis-inducing effect of valproic acid combined with arsenic trioxide on RPMI 8226 cells and its mechanism]. | 2014 Aug |
1 |
| 5 |
21779797 | Arsenic trioxide induces human pulmonary fibroblast cell death via the regulation of Bcl-2 family and caspase-8. | 2012 Apr |
2 |
| 6 |
20953137 | Arsenic trioxide-mediated growth inhibition of myeloma cells is associated with an extrinsic or intrinsic signaling pathway through activation of TRAIL or TRAIL receptor 2. | 2010 Dec 1 |
2 |
| 7 |
18173754 | P38 MAPK inhibition enhancing ATO-induced cytotoxicity against multiple myeloma cells. | 2008 Jan |
1 |
| 8 |
18359480 | Quercetin decreases intracellular GSH content and potentiates the apoptotic action of the antileukemic drug arsenic trioxide in human leukemia cell lines. | 2008 May 15 |
1 |
| 9 |
18566239 | Arsenic trioxide decreases AKT protein in a caspase-dependent manner. | 2008 Jun |
1 |
| 10 |
17673311 | Arsenic trioxide sensitizes promonocytic leukemia cells to TNFalpha-induced apoptosis via p38-MAPK-regulated activation of both receptor-mediated and mitochondrial pathways. | 2007 Nov |
1 |
| 11 |
16434995 | TRAIL sensitisation by arsenic trioxide is caspase-8 dependent and involves modulation of death receptor components and Akt. | 2006 Feb 13 |
3 |
| 12 |
16685442 | Combination treatment with arsenic trioxide and sulindac augments their apoptotic potential in lung cancer cells through activation of caspase cascade and mitochondrial dysfunction. | 2006 Jun |
1 |
| 13 |
17145888 | Buthionine sulfoximine enhancement of arsenic trioxide-induced apoptosis in leukemia and lymphoma cells is mediated via activation of c-Jun NH2-terminal kinase and up-regulation of death receptors. | 2006 Dec 1 |
1 |
| 14 |
16007134 | Arsenic trioxide induces regulated, death receptor-independent cell death through a Bcl-2-controlled pathway. | 2005 Oct 27 |
1 |
| 15 |
16010437 | Arsenic trioxide mediates intrinsic and extrinsic pathways of apoptosis and cell cycle arrest in acute megakaryocytic leukemia. | 2005 Aug |
1 |
| 16 |
14726646 | Arsenic trioxide and paclitaxel induce apoptosis by different mechanisms. | 2004 Mar |
1 |
| 17 |
12531793 | Arsenic trioxide-induced apoptosis in myeloma cells: p53-dependent G1 or G2/M cell cycle arrest, activation of caspase-8 or caspase-9, and synergy with APO2/TRAIL. | 2003 May 15 |
2 |
| 18 |
12684647 | Arsenic trioxide induces apoptosis in leukemia/lymphoma cell lines via the CD95/CD95L system. | 2003 May-Jun |
1 |
| 19 |
12851490 | Arsenic trioxide selectively induces early and extensive apoptosis via the APO2/caspase-8 pathway engaging the mitochondrial pathway in myeloma cells with mutant p53. | 2003 Jul-Aug |
2 |
| 20 |
11866444 | Arsenic trioxide-induced apoptosis and its enhancement by buthionine sulfoximine in hepatocellular carcinoma cell lines. | 2002 Mar 8 |
1 |
| 21 |
11021749 | Involvement of CD95-independent caspase 8 activation in arsenic trioxide-induced apoptosis. | 2000 Oct |
3 |